JO
HUMA icon

John Overdeck’s Humacyte HUMA Stock Holding History

John Overdeck’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Sell
29,548
-147,988
-83% -$137K ﹤0.01% 4978
2026
Q1 		$108K Sell
177,536
-1,313,931
-88% -$1.37M ﹤0.01% 4379
2025
Q4 		$1.43M Buy
1,491,467
+124,883
+9% +$177K ﹤0.01% 2696
2025
Q3 		$2.38M Sell
1,366,584
-170,797
-11% -$335K ﹤0.01% 2016
2025
Q2 		$3.21M Buy
1,537,381
+950,940
+162% +$1.83M 0.01% 1521
2025
Q1 		$1,000K Sell
586,441
-332,656
-36% -$1.25M ﹤0.01% 2175
2024
Q4 		$4.64M Sell
919,097
-149,142
-14% -$738K 0.01% 1149
2024
Q3 		$5.81M Sell
1,068,239
-73,803
-6% -$487K 0.01% 1008
2024
Q2 		$5.48M Buy
1,142,042
+1,116,414
+4,356% +$5.81M 0.01% 968
2024
Q1 		$79.7K Sell
25,628
-307,048
-92% -$1.03M ﹤0.01% 2851
2023
Q4 		$945K Buy
332,676
+215,074
+183% +$552K ﹤0.01% 2115
2023
Q3 		$345K Buy
+117,602
New +$389K ﹤0.01% 2437
2023
Q1 		– Sell
-24,567
Closed -$51.8K – 3064
2022
Q4 		$51.8K Buy
+24,567
New +$74.6K ﹤0.01% 2587
2022
Q1 		– Sell
-31,061
Closed -$225K – 3404
2021
Q4 		$225K Buy
+31,061
New +$307K ﹤0.01% 3844

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

John Overdeck's HUMA Position: Q2 2026 in Review

John Overdeck reduced its Humacyte (HUMA) stake by 83% in Q2 2026, selling an estimated $137K and leaving 29,548 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4978.

John Overdeck first reported a position in HUMA in Q4 2021 and has held it in 14 quarters since. The position peaked at $5.81M in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • John Overdeck held 29,548 shares of Humacyte worth $23.1K as of Q2 2026.
  • John Overdeck sold 147,988 Humacyte shares in Q2 2026, an estimated $137K.
  • Humacyte made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4978 holding.
  • John Overdeck first reported a position in Humacyte in Q4 2021 and has held it in 14 quarters since.
  • John Overdeck's Humacyte position peaked at $5.81M in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.